Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8224405 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 5 Pages |
Abstract
Pretreatment eMRI findings predict for biochemical recurrence in intermediate- and high-risk prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy. Gleason score and the presence of ECE on MRI were the only significant predictors of biochemical relapse in this group of patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nadeem M.D., Asim M.D., Oguz M.D., Xin Ph.D., Marisa A. M.D., Brett M.D., Hedvig M.D., Michael J. M.D.,